{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:50:49Z","timestamp":1793332249660,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To compare the outcome of adjuvant intrastromal Amphotericin B (ISAMPB) and Voriconazole (ISVCZ) in managing refractory deep stromal fungal keratitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We reviewed the records of patients treated between January 2020 and December 2022 for microbiologically confirmed refractory fungal keratitis that had worsened despite treatment with topical Natamycin, with or without oral Ketoconazole. These patients received adjuvant therapy with either intrastromal Amphotericin B (ISAMPB, 5\u201310 \u00b5g\/0.1 ml) or intrastromal Voriconazole (ISVCZ, 50 \u00b5g\/0.1 ml). The demographics, clinical profiles, and outcomes of the ISAMPB and ISVCZ groups were compared, with key outcomes being the proportion of patients achieving clinical resolution and the number of therapeutic keratoplasty procedures performed. A logistic regression model was constructed for multivariate analysis to adjust for potential confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Medical records of 49 patients with refractory fungal keratitis were analyzed: 34 (69.3%) received ISAMPB, and 15 (30.6%) received ISVCZ. The overall mean LogMAR visual acuity was 1.90 \u00b1 0.6, and the infiltrate size averaged 4.28 \u00b1 1.30 mm vertically and 4.3 \u00b1 1.4 mm horizontally.\n                      <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Fusarium<\/jats:italic>\n                      each accounted for 32.3% of ISAMPB patients, and 40% and 20% of ISVCZ patients, respectively. The median time to intrastromal injection was 12 days for ISAMPB and 11 days for ISVCZ. ISAMPB achieved resolution in 53% of cases, while 41.1% required TPK; ISVCZ resolved in 10%, with 86% requiring TPK (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). The adjusted odds ratio for ISAMPB response was 21.98 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.013).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Intrastromal Amphotericin B has been shown to provide better outcomes than Voriconazole in the treatment of deep stromal refractory fungal keratitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_2765_24","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T07:00:09Z","timestamp":1751266809000},"page":"1044-1049","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Comparative efficacy of intrastromal amphotericin B versus voriconazole in treating deep-stromal refractory fungal keratitis"],"prefix":"10.4103","volume":"73","author":[{"given":"Charul","family":"Singh","sequence":"first","affiliation":[{"name":"Shantilal Shanghvi Cornea Institute, LV Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Mohanty","sequence":"additional","affiliation":[{"name":"Shantilal Shanghvi Cornea Institute, LV Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raksheeth N","family":"Rajagopal","sequence":"additional","affiliation":[{"name":"Shantilal Shanghvi Cornea Institute, LV Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Hasnat","family":"Ali","sequence":"additional","affiliation":[{"name":"Prof. Brien Holden Eye Research Centre, LV Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joveeta","family":"Joseph","sequence":"additional","affiliation":[{"name":"Jhaveri Microbiology Centre, LV Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupesh","family":"Bagga","sequence":"additional","affiliation":[{"name":"Shantilal Shanghvi Cornea Institute, LV Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"R1-20260421","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/IIO.0b013e318074e727","article-title":"Epidemiology and treatment of fungal corneal ulcers","volume":"47","author":"Ou","year":"2007","journal-title":"Int Ophthalmol Clin"},{"key":"R2-20260421","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0301-4738.53051","article-title":"Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: Experience of over a decade","volume":"57","author":"Gopinathan","year":"2009","journal-title":"Indian J Ophthalmol"},{"key":"R3-20260421","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jtos.2021.12.001","article-title":"Fungal keratitis: A review of clinical presentations, treatment strategies and outcomes","volume":"24","author":"Sharma","year":"2022","journal-title":"Ocul Surf"},{"key":"R4-20260421","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/archophthalmol.2010.102","article-title":"Comparison of natamycin and voriconazole for the treatment of fungal keratitis","volume":"128","author":"Prajna","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R5-20260421","first-page":"597","article-title":"Natamycin in the treatment of fungal keratitis: A systematic review and Meta-analysis","volume":"8","author":"Qiu","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"R6-20260421","first-page":"2","article-title":"[Several problems of diagnosis and treatment in fungal keratitis in China]","volume":"49","author":"Shi","year":"2013","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"R7-20260421","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/jcm10061178","article-title":"Topical corticosteroids and fungal keratitis: A review of the literature and case series","volume":"10","author":"Knutsson","year":"2021","journal-title":"J Clin Med"},{"key":"R8-20260421","doi-asserted-by":"crossref","first-page":"e0196741","DOI":"10.1371\/journal.pone.0196741","article-title":"Clinical analysis of fungal keratitis in patients with and without diabetes","volume":"13","author":"Dan","year":"2018","journal-title":"PLoS One"},{"key":"R9-20260421","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/ICO.0000000000002825","article-title":"Predictive factors for resolution of dematiaceous fungal keratitis","volume":"41","author":"Chaudhary","year":"2022","journal-title":"Cornea"},{"key":"R10-20260421","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/ICO.0000000000001781","article-title":"Management algorithm for fungal keratitis: The TST (topical, systemic, and targeted therapy) protocol","volume":"38","author":"Sharma","year":"2019","journal-title":"Cornea"},{"key":"R11-20260421","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/jop.2017.0139","article-title":"Comparison of the ocular penetration and pharmacokinetics between natamycin and voriconazole after topical instillation in rabbits","volume":"34","author":"Zhao","year":"2018","journal-title":"J Ocul Pharmacol Ther"},{"key":"R12-20260421","doi-asserted-by":"crossref","first-page":"105857","DOI":"10.1016\/j.ejps.2021.105857","article-title":"Novel water soluble sterile natamycin formulation (Natasol) for fungal keratitis","volume":"163","author":"Velpandian","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"R13-20260421","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/eye.2017.228","article-title":"Early deep anterior lamellar keratoplasty for fungal keratitis poorly responsive to medical treatment","volume":"31","author":"Sabatino","year":"2017","journal-title":"Eye (Lond)"},{"key":"R14-20260421","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/pharmaceutics15041091","article-title":"Intrastromal injections in the management of infectious keratitis","volume":"15","author":"Zemba","year":"2023","journal-title":"Pharmaceutics"},{"key":"R15-20260421","doi-asserted-by":"crossref","first-page":"1875627","DOI":"10.1155\/2018\/1875627","article-title":"Corneal debridement combined with intrastromal voriconazole for recalcitrant fungal keratitis","volume":"2018","author":"Sun","year":"2018","journal-title":"J Ophthalmol"},{"key":"R16-20260421","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3390\/microorganisms12050922","article-title":"Efficacy of the combined intrastromal injection of voriconazole and amphotericin B in recalcitrant fungal keratitis","volume":"12","author":"Moramarco","year":"2024","journal-title":"Microorganisms"},{"key":"R17-20260421","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.4103\/ijo.IJO_1952_18","article-title":"Outcomes of therapeutic penetrating keratoplasty in 198 eyes with fungal keratitis","volume":"67","author":"Mundra","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"R18-20260421","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ajo.2008.02.023","article-title":"Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis","volume":"146","author":"Prakash","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R19-20260421","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1136\/bjo.2010.192815","article-title":"Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: Case series","volume":"95","author":"Sharma","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R20-20260421","first-page":"1075","article-title":"Ineffectiveness of intrastromal voriconazole for filamentous fungal keratitis","volume":"8","author":"Niki","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"R21-20260421","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bjophthalmol-2014-305412","article-title":"Intrastromal voriconazole for deep recalcitrant fungal keratitis: A case series","volume":"99","author":"Kalaiselvi","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R22-20260421","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/archopht.123.12.1721","article-title":"Intracorneal injection of amphothericin B for recurrent fungal keratitis and endophthalmitis","volume":"123","author":"Garcia-Valenzuela","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R23-20260421","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/OPTH.S135112","article-title":"Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: A retrospective study","volume":"11","author":"Nada","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"R24-20260421","doi-asserted-by":"crossref","first-page":"3436415","DOI":"10.1155\/2016\/3436415","article-title":"A Combination of intrastromal and intracameral injections of amphotericin B in the treatment of severe fungal keratitis","volume":"2016","author":"Hu","year":"2016","journal-title":"J Ophthalmol"},{"key":"R25-20260421","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/ICL.0000000000000723","article-title":"Combined intrastromal voriconazole and amphotericin B treatment for persistent fungal keratitis","volume":"46","author":"Aydin","year":"2020","journal-title":"Eye Contact Lens"},{"key":"R26-20260421","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/02713683.2013.847961","article-title":"Toxicity and pharmacokinetics of intrastromal injection of amphotericin B in a rabbit model","volume":"39","author":"Qu","year":"2014","journal-title":"Curr Eye Res"},{"key":"R27-20260421","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00003226-200210000-00002","article-title":"Evaluation of corneal scraping smear examination methods in the diagnosis of bacterial and fungal keratitis: A survey of eight years of laboratory experience","volume":"21","author":"Sharma","year":"2002","journal-title":"Cornea"},{"key":"R28-20260421","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.2147\/OPTH.S301878","article-title":"Comparison of safety and efficacy of intrastromal injections of voriconazole, amphotericin B and natamycin in cases of recalcitrant fungal keratitis: A randomized controlled trial","volume":"15","author":"Saluja","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"R29-20260421","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ophtha.2019.03.020","article-title":"Mycotic antimicrobial localized injection: A randomized clinical trial evaluating intrastromal injection of voriconazole","volume":"126","author":"Narayana","year":"2019","journal-title":"Ophthalmology"},{"key":"R30-20260421","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-0041-111814","article-title":"Repeated intrastromal injections of voriconazole in combination with corneal debridement for recalcitrant fungal keratitis - A case series","volume":"233","author":"Guber","year":"2016","journal-title":"Klin Monbl Augenheilkd"},{"key":"R31-20260421","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00003226-200110000-00009","article-title":"Intracameral amphotericin B: Initial experience in severe keratomycosis","volume":"20","author":"Kaushik","year":"2001","journal-title":"Cornea"},{"key":"R32-20260421","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12348-024-00418-w","article-title":"Association between in vitro susceptibility and clinical outcomes in fungal keratitis","volume":"14","author":"Lu","year":"2024","journal-title":"J Ophthalmic Inflamm Infect"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2765_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:54:38Z","timestamp":1786647278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2765_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2765_24","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"2024-11-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}